| 3-MA | 3-Methyladenine |
| Abs | Antibodies |
| ACPA | Anti-Citrullinated Antibodies |
| ACR | American College of Rheumatology |
| ADA | Antidrug Auto-antibodies |
| AKT | Protein Kinase B |
| AMPA | Anti-Modified Protein Antibody |
| Anti-CarP | Antibodies targeting Carbamylated Proteins |
| Anti-RA33 | Antibodies to the heterogeneous nuclear ribonucleoprotein A2/B1 |
| APC | Antigen-Presenting Cell |
| APRIL | Proliferation-Inducing Ligand |
| ATG | Anti-Thymocyte Globulin |
| ATP | Adenosine Triphosphate |
| BAFF | B-cell Activating Factor |
| BCR | B-Cell Receptor |
| CCP | Cyclic Citrullinated Peptide |
| CD | Cluster of Differentiation |
| CD4+ CTL | CD4+ T-cells with Cytotoxic Potential |
| CIA | Collagen Induced Arthritis |
| CII | Collagen type II |
| CMV | Cytomegalovirus |
| COX | Cyclooxygenase |
| CQ | Chloroquine |
| CTLA4 | Cytotoxic T-lymphocyte-associated Protein 4 |
| CXCL | Chemokine Ligand |
| DNA | Deoxyribonucleic Acid |
| DAS | Disease Activity Score |
| DMARDs | Disease-modifying Anti-Rheumatic Drugs |
| DNMT | DNA-Methyltransferase |
| EA2 | Endophilin A2 |
| ELISA | Enzyme Linked Immunosorbent Assay |
| EMA | European Medicines Agency |
| EOMES | Eomesodermin gene |
| ER | Endoplasmic Reticulum |
| EULAR | European League Against Rheumatism |
| EV | Extracellular Vesicle |
| FDA | Food and Drug Administration |
| FLS | Fibroblast-Like Synoviocytes |
| FOXP3 | Forkhead box P3 |
| GC | Glucocorticoid |
| GWAS | Genome Wide Association Studies |
| HAT | Histone Acetyltransferase |
| HCQ | Hydroxy Chloroquine |
| HDAC | Histone Deacetylase |
| HLA | Human Leukocyte Antigen |
| HLA-DRB1 | HLA class II Histocompatibility Antigen DRB1 beta chain |
| IFN | Interferon |
| IL | Interleukin |
| JAK | Janus-Activated Kinase |
| LC3-II | Microtubule-associated proteins 1A/1B light chain 3B |
| LTQ-ESI-MS | Linear ion-trap Electrospray Ionization Mass Spectrometry |
| mAb | Monoclonal Antibody |
| MHC II | Major histocompatibility Complex class II |
| MMP | Matrix-Metallo-Proteinase |
| mRNA | Messenger RNA |
| MSC | Mesenchymal Stem Cell |
| mTORC1 | mTOR complex 1 |
| MTX | Methotrexate |
| NADPH | Nicotinamide Adenine Dinucleotide Phosphate |
| NCF1 | Neutrophil Cytosol Factor 1 |
| ncRNA | Noncoding RNA |
| NF-κB | Nuclear Factor kappa B |
| NO | Nitric Oxide |
| NOS2 | Nitric Oxide Synthase 2 |
| NOX2 | NADPH Oxidase 2 |
| NSAID | Nonsteroidal Anti-Inflammatory Drug |
| OA | Osteoarthritis |
| PAD | Peptidyl Arginine Deiminase |
| PBMC | Peripheral Blood Mononuclear Cell |
| PC | Plasma Cell |
| PI3K | Phosphoinositide 3-Kinase |
| Prdm1 | PR domain Zinc finger protein1 |
| PTK | Protein-Tyrosine-Kinase |
| PTPN22 | Protein tyrosine phosphatase, non-receptor type 22 |
| QTL | Quantitative trait Loci |
| RA | Rheumatoid Arthritis |
| RA33 | Heterogenous nuclear ribonucleoprotein A2/B1 |
| RANKL | Receptor Activator of NF-κB Ligand |
| RF | Rheumatoid Factor |
| RNA | Ribonucleic Acid |
| ROS | Reactive Oxygen Species |
| SNP | Single Nucleotide Polymorphism |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| Syk | Spleen tyrosine kinase |
| TACI | Transmembrane Activator and CAML Interactor CD Antigen |
| TCR | T-cell Receptor |
| Tfh | Follicular T-helper Cell |
| TGF | Tumor Growth Factor |
| Th | T-helper Cell |
| TLR | Toll-Like Receptor |
| TNF | Tumor Necrosis Factor |
| TNFi | Tumor Necrosis Factor inhibitor |
| Treg | Regulatory T-Cell |
| TYK2 | Tyrosine kinase 2 |